Demirer, T. Et Al. 2000. Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.. BLOOD , vol.96, no.11 .

Demirer, T., Ilhan, O., Ayli, M., Arat, M., Fen, T., Haznedar, R., ... Ozcan, M.(2000). Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.. BLOOD , vol.96, no.11.

Demirer, TANER Et Al. "Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.," BLOOD , vol.96, no.11, 2000

Demirer, TANER Et Al. "Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.." BLOOD , vol.96, no.11, 2000

Demirer, T. Et Al. (2000) . "Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.." BLOOD , vol.96, no.11.

@article{article, author={TANER DEMİRER Et Al. }, title={Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.}, journal={BLOOD}, year=2000}